Gainers
Adagio Therapeutics, Inc. (NASDAQ: ADGI) shares jumped 123.3% to settle at $14.18 on Thursday after traders circulated rumors of a reiterated Buy rating and $46 price target from Jefferies.
Bird Set to Operate up to 1,000 Micro-EVs in Reno
Bird Global, Inc. (NYSE:BRDS), a leader in environmentally friendly electric transportation, today announced that it was awarded a conditional exclusive three-year